Back to Search
BADAR MIAN, M.D.
M.D.
Urology Physician
NPI: 1285742353IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
221445(NY)
CMS Specialties
PrimaryUROLOGY
Education
OTHER
Class of 1991
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (17)
Role of prostate biopsy schemes in accurate prediction of Gleason scores.
PMID 16461089·Urology·2006
8-other
Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.
PMID 12429311·Urology·2002
8-other
Intraprostatic adipose tissue: a study of 427 whole mount radical prostatectomy specimens.
PMID 19121845·Hum Pathol·2009
8-other
Complete eversion of the urinary bladder: presentation, review, and algorithm for management.
PMID 19155933·Obstet Gynecol·2009
5-case
Altered redox status accompanies progression to metastatic human bladder cancer.
PMID 18930813·Free Radic Biol Med·2009
8-other
High risk prostate cancer: evolving definition and approach to management.
PMID 19046490·Can J Urol·2008
6-review
Molecularly targeted therapies for renal cell cancer: TRAIL research advances.
PMID 17437767·J Urol·2007
8-other
Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells.
PMID 17974967·Cancer Res·2007
7-preclinical
Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era.
PMID 15592031·J Urol·2005
8-other
Expression of cysteine protease protein 32 in prostatic adenocarcinoma correlates with tumor grade.
PMID 15163235·Arch Pathol Lab Med·2004
8-other
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
PMID 12912969·Clin Cancer Res·2003
7-preclinical
Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
PMID 12384530·Cancer Res·2002
7-preclinical
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
PMID 12171905·Clin Cancer Res·2002
7-preclinical
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.
PMID 12107097·Am J Pathol·2002
7-preclinical
Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.
PMID 11912386·J Urol·2002
8-other
Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.
PMID 11743277·J Urol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23 HACKETT BLVD
ALBANY, NY 12208 - Phone
- (518) 262-3341
Quick Facts
- NPI
- 1285742353
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Clinical Trials
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile